ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,743.73
-0.03%
Dow Jones
42,409.22
0.56%
US Dollar vs MXN
19.704
0.41%
Brent Oil
71.55
0.85%
Bitcoin
66,259.66
1.65%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Morphic Holding Inc (MORF)

  7. Morphic Holding Inc (MORF) Noticias

MORF

Morphic (MORF)

Morphic Holding Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MORF
FechaHoraFuenteTítuloSímboloCompañía
26/08/202406:39Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:MORFMorphic Holding Inc
20/08/202418:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MORFMorphic Holding Inc
16/08/202415:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MORFMorphic Holding Inc
16/08/202415:14Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:MORFMorphic Holding Inc
16/08/202415:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MORFMorphic Holding Inc
16/08/202408:13Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MORFMorphic Holding Inc
16/08/202407:38PR Newswire (US)Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel DiseaseNASDAQ:MORFMorphic Holding Inc
31/07/202408:02PR Newswire (US)Kuehn Law Encourages MORF, PFC, WSBC, and ACNB Investors to Contact Law FirmNASDAQ:MORFMorphic Holding Inc
25/07/202406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MORFMorphic Holding Inc
19/07/202405:26Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:MORFMorphic Holding Inc
09/07/202405:54IH Market NewsBP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More NewsNASDAQ:MORFMorphic Holding Inc
08/07/202415:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MORFMorphic Holding Inc
08/07/202406:27Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MORFMorphic Holding Inc
08/07/202405:45PR Newswire (US)Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel DiseaseNASDAQ:MORFMorphic Holding Inc
31/05/202407:00GlobeNewswire Inc.Morphic to Participate in Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
21/05/202407:00GlobeNewswire Inc.Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking CellsNASDAQ:MORFMorphic Holding Inc
09/05/202415:05GlobeNewswire Inc.Morphic to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
25/04/202406:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024NASDAQ:MORFMorphic Holding Inc
19/03/202407:00GlobeNewswire Inc.Morphic Appoints Dr. Simon Cooper as Chief Medical OfficerNASDAQ:MORFMorphic Holding Inc
05/03/202415:05GlobeNewswire Inc.Morphic to Participate in March Investor ConferencesNASDAQ:MORFMorphic Holding Inc
22/02/202406:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MORFMorphic Holding Inc
22/02/202406:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MORFMorphic Holding Inc
22/02/202406:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023NASDAQ:MORFMorphic Holding Inc
03/01/202415:05GlobeNewswire Inc.Morphic to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
10/11/202307:00GlobeNewswire Inc.Morphic to Present at November Investor ConferencesNASDAQ:MORFMorphic Holding Inc
03/11/202306:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023NASDAQ:MORFMorphic Holding Inc
09/10/202307:00GlobeNewswire Inc.Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data SetNASDAQ:MORFMorphic Holding Inc
26/09/202315:10GlobeNewswire Inc.Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of AbsenceNASDAQ:MORFMorphic Holding Inc
22/09/202316:30GlobeNewswire Inc.Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023NASDAQ:MORFMorphic Holding Inc
29/08/202307:00GlobeNewswire Inc.Morphic Announces Participation in 2023 Wells Fargo Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
 Showing the most relevant articles for your search:NASDAQ:MORF

Su Consulta Reciente

LSE
72RM
Wells Fargo 49
LATK
SUSHIBTC
SushiToken
BIT
UB73S7
Unicredit Bank
COIN
WITETH
Witnet
CEGG
SSPBTC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados